Trial Details
COMPLETEDBasic Information
| Clinical ID | c227 |
|---|---|
| Identifier | NCT06935942 |
| Trial Title | The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | BIOLOGICAL: Ustekinumab - Standard Dosage |
Participant Information
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
|---|---|
| City | Zhejiang |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2020-01-01 |
|---|---|
| Primary Completion Date | 2025-01-01 |
| Completion Date | 2025-01-01 |